Interventions for treating oral candidiasis for patients with cancer receiving treatment
Interventions for treating oral candidiasis for patients with cancer receiving treatment
Cochrane Review
10 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Overall survival
RT or CRT alone |
0.82 | - | - | Not assessed |
|
Locoregional control
RT or CRT alone |
0.68 | - | - | Not assessed |
|
Progression-free survival
RT or CRT alone |
nan | - | - | Not assessed |
|
Adverse effects (skin toxicity/acneiform rash - all grades)
RT or CRT alone |
6.56 | - | - | Not assessed |
|
Adverse effects (skin toxicity/acneiform rash - grades ≥ 3)
RT or CRT alone |
17.72 | - | - | Not assessed |
|
Disease-free Survival
Standard therapy (either RT or CRT alone) |
1.51 | - | - | Not assessed |
|
Progression-free Survival
Standard therapy (either RT or CRT alone) |
0.8 | - | - | Not assessed |
|
Adverse effects (gastrointestinal complaints - all grades)
Standard therapy (either RT or CRT alone) |
15.53 | - | - | Not assessed |
|
Disease-free survival
Standard therapy (surgery) alone |
0.66 | - | - | Not assessed |
|
Adverse effects
Standard therapy (surgery) alone |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD010341 |
| Outcomes: | 10 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
10